# FDA Inspection 802681 - Carter BloodCare at Lockheed - October 10, 2012

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-lockheed/1449ce27-9b23-4af2-bd29-28a76649cabe
Source feed: FDA_Inspections

> FDA Inspection 802681 for Carter BloodCare at Lockheed on October 10, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 802681
- Company Name: Carter BloodCare at Lockheed
- Inspection Date: 2012-10-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1247270 - 2024-08-19](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-lockheed/92915f43-b5c2-440d-967c-b1cd8b3c6901)
- [FDA Inspection 1079842 - 2019-01-29](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-lockheed/36dcc94c-0051-43d2-9afc-854d8705e0c8)
- [FDA Inspection 1021119 - 2017-07-18](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-lockheed/b436aa05-d207-4d4b-9f2a-0b77dd45bba4)
- [FDA Inspection 910023 - 2015-01-15](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-lockheed/b4153b1b-48ed-4bbd-ac17-21717d6685f5)
- [FDA Inspection 694616 - 2010-10-09](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-lockheed/a3c36819-5428-423d-a83d-9f905a664e06)

Company: https://www.keypedia.com/companies/carter-bloodcare-at-lockheed/8d6f2f39-2bb9-45db-b193-85863e0a1f21

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d